GlaxoSmithKline logo

Patient group funding

The Cure Parkinson's Trust

The Cure Parkinson’s Trust is a patient led charity that funds research which will have an impact on the lives of people with Parkinson’s, with the hope of an eventual cure for the condition.  

The Trust was founded in 2005 with the clear goal of finding a cure for Parkinson’s disease by investing in under resourced and under funded projects that offer a real hope of a cure in the future.  Its primary role is identifying, funding and evaluating research projects, as well as hosting scientific forums to bring together relevant scientists within the field, to discuss key areas of research and technology.

The Trust’s fundraising arm is called ‘Movers and Shakers’ a name adopted by the co-founders, who between them have already generated significant funds for Parkinson’s: Sir David Jones, former chairman of Next Plc, Sir Richard Nichols, former Lord Mayor of London, Air Vice Marshal Michael Dicken and Tom Isaacs, author, fundraising walker and renowned Parkinson's campaigner.

We have supported this organisation since 2008.

During 2010:

  • We gave £2,500 towards delegate attendance of 5 people with Parkinson’s at the World Parkinson's Congress in Glasgow, September 2010

Our support represents 0.31% of their overall income



During 2009:

  • We gave £200 in respect of a presentation to the Neurosciences Centre of Excellence and Neurology Marketing Team held on 10th February at GSK House, and a presentation at The British Geriatric Society Spring Meeting in Bournemouth on 3rd April.
  • We purchased 43 books entitled “Shake Well Before Use” to the sum of £729.84.

Our support represents 0.13% of their overall income.

We also provided in kind support by PR agency Cohn & Wolfe, for a Parkinson’s Self Assessment Tool project, to the sum of £27,473.



During 2008:

  • We gave a grant of £65,000 in support of the “Get a move on campaign” to develop a simple measurement tool for patients to be able to monitor the progression of their Parkinson’s disease symptoms. In addition, we have committed to provide allocated time of a GSK Parkinson’s Nurse Advisor to participate in steering committee meetings and provide ad hoc review and advice on documentation and materials.

Our support represents 11% of their overall funding.